Table 2 All-cause mortality (six study populations; 11 articles)
Reference | Assessment | Mortality/survival |
|---|---|---|
Viana-Tejedor et al. 2015 [23] | Mortality in years 1–5 in patients alive 1 year after MIa | • Mortality 1988–1993: 26.9% (42/156); 1994–1998: 32.5% (66/203); 1999–2003: 23.7% (57/241); 2004–2008: 15.4% (48/311) • 1-year and 5-year mortality decreased significantly over the 20-year period of study (p < 0.001) |
Jernberg et al. 2011 [13] | Risk of death up to 12 years after event | • Time trends show risk of death 1996–1997 > 1998–1999 > 2000–2001 > 2002–2003 > 2004–2005 > 2006–2007b |
Nielsen et al. 2014 [18] | Survival probability for 4 years after event | • For men, time trends show survival probability 1987–1991 < 1992–1996 < 1997–2001 < 2002–2006b • For women, time trends show survival probability 1987–1991 < 1992–1996 < 1997–2001, but levels for 2002–2006 were similar to those for 1997–2001b |
Isaksson et al. 2011 [12] | Survival up to 24 years after event | • Time trends show survival 1985–1988 < 1989–1994 < 1995–2000 < 2001–2006b • Survival in women was generally higher than that for men before 2000, but similar for men and women after 2000 |
Nauta et al. 2011 [15] | Survival for 3 years after event in patients with NSTEMI | • Time trends show survival 1985–1990 < 1990–2000 < 2000–2008b |
Snelder et al. 2013 [22] | Mortality for up to 10 years after event in patients with STEMI | • Time trends show mortality 1985–1990 > 1990–2000 > 2000–2008b |
Nauta et al. 2013 [17] | Mortality for up to 20 years after event according to renal function | • Time trends for mortality stage 4–5 chronic kidney disease > stage 3 > stage 2 > normal kidney functionb |
Nauta et al. 2012 [14] | Mortality for up to 20 years after event according to diabetes status | • Mortality was higher in patients with diabetes than in those without • There was an increase in the risk of presenting with diabetes during the study period • Time trends show mortality 1985–1989 > 1990–1999 > 2000–2008 in patients with diabetes, and 1985–1989 ≈ 1990–1999 > 2000–2008 in patients without diabetesb |
Deckers et al. 2013 [11] | Mortality for up to 20 years after event according to glucose levels | • Mortality was highest in patients with severe hyperglycemia, followed by those with mild hyperglycemia, and was lowest in those with normal glucose levelsb |
Nauta et al. 2012 [16] | Mortality for up to 20 years after event according to sex | • From 1985 to 2008, age at presentation increased and patients were more likely to have diabetes or anemia at presentation • Adjusted 20-year mortality was significantly lower in women than in men |
Rapsomaniki et al. 2014 [20] | Cumulative all-cause mortality up to 5.5 years after eventc | • Mortality in stable patients after NSTEMI > after STEMIb |